Quentin Campbell-Hewson Selected Research

Quentin Campbell-Hewson Research Topics

3	Neoplasms (Cancer) 01/2021 - 01/2015
2	Osteosarcoma (Osteogenic Sarcoma) 11/2021 - 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Disease Progression 01/2021
1	Dehydration (Water Stress) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Proteinuria 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Vomiting 01/2019
1	Alveolar Soft Part Sarcoma 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Neutropenia 01/2015
1	Anemia 01/2015

2	lenvatinibIBA 11/2021 - 01/2021
2	Ifosfamide FDA LinkGeneric 11/2021 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
1	SteroidsIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 11/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	cediranib (AZD2171)IBA 01/2019
1	1- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA 01/2015
1	Aurora Kinase AIBA 01/2015
1	Aurora KinasesIBA 01/2015

3	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
1	Critical Care (Surgical Intensive Care) 01/2022
1	Immunomodulation 01/2022
1	Therapeutics 01/2021
1	Radiotherapy 01/2019